CompoAtlas

Huile de phoque

Natural health product licensed in Canada

Other names
Huile de loups marin, Huile de phoque Océan
Licence holder
Total Ocean
NPN or DIN-HM
80112019
Status
Inactive licence
Licence date
11 August 2021
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de phoque

Source : Pagophilus groenlandicus - petit lard

Potency : 225 mg Acide éicosapentaénoïque

5 mLNot calculated
Huile de phoque

Source : Halichoerus grypus - petit lard

Potency : 225 mg Acide éicosapentaénoïque

5 mLNot calculated
Huile de phoque

Source : Pagophilus groenlandicus - petit lard

Potency : 180 mg Acide docosapentanoïque

Not specifiedNot calculated
Huile de phoque

Source : Halichoerus grypus - petit lard

Potency : 180 mg Acide docosapentanoïque

Not specifiedNot calculated

Non-medicinal ingredients

dl-alpha tocophérol

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years5 mL1 Tous les jours

Uses authorised in Canada

Source d'acide eicosapentanoïque (AEP), d'acide docosahexanéoïque (ADH) et d'acide docosapentanoïque (ADP) pour le maintien d'une bonne santé. Source d'acides gras oméga-3 pour le maintien d'une bonne santé.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80112019

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line